Spear Bio
PrivateLast Round
Series A
Jul 29, 2024
Total Funding Raised
$45M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Spear Bio is a biotechnology company that develops ultrasensitive immunoassay technology for protein biomarker detection in research and clinical diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Spear Bio Comparables
Compare Spear Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alamar Biosciences | 76% | |
| Quantum Diamond Technologies Inc. | 76% | |
| Bio-Techne Corporation | 74% |
Spear Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 29, 2024 | ||||
| Seed | Nov 29, 2023 |
Key People
Founding team and executive leadership
Spear Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CDH Investments | Series A, Seed |
| Maverick Ventures | Seed, Series A |
| Yonjin Capital | Series A |
| Yonghua Capital | Seed |
| Foresite Capital | Series A |
| CDH Investments | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 46% MoM, from 4.1K to 6K.
- Jun 30, 2026
Commercial SPEAR S.W.I.F.T. instrument platform now being installed at customer sites.
Recent news
Latest coverage and updates
- receives_awardAug 11, 2026
Spear Bio Inc. received award 2026 R&D 100 Award at R&D 100 Awards on Aug 11th '26.
- attends_eventJul 7, 2026
Spear Bio Inc. will attend event Alzheimer's Association International Conference(R) 2026 on Jul 12th '26.
- launchesJul 7, 2026
Spear Bio Inc. will launch novel Alzheimer's disease immunoassays and fully automated instrument platform at Alzheimer's Association International Conference(R) 2026 on Jul 12th '26.
- attends_eventJul 7, 2026
Spear Bio Inc. will attend event AAIC 2026 on Jul 12th '26.
Spear Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Spear Bio's valuation, stock price, and market status.
Is Spear Bio a public or private company?
Spear Bio is a private company.
What is the current stock price of Spear Bio?
Spear Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Spear Bio worth (valuation)?
Valuation information for Spear Bio is not publicly available.
Can I buy Spear Bio stock?
Spear Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Spear Bio's last funding round?
Spear Bio's most recent funding round was Series A on July 29, 2024.
Who are the main investors in Spear Bio?
Key investors in Spear Bio include CDH Investments, Foresite Capital.
Will Spear Bio IPO soon?
No public IPO plans have been announced for Spear Bio.
How can I track Spear Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Spear Bio's secondary market activity and sign up for updates.